Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1567254, 7 pages
http://dx.doi.org/10.1155/2016/1567254
Research Article

Biosensor for Hepatocellular Injury Corresponds to Experimental Scoring of Hepatosplenic Schistosomiasis in Mice

1Division of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, 18057 Rostock, Germany
2Fraunhofer Institute for Cell Therapy and Immunology, 04103 Leipzig, Germany
3Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria
4Anesthesiology and Intensive Care Medicine, Medical Faculty of the University of Rostock, 18057 Rostock, Germany

Received 5 January 2016; Accepted 17 May 2016

Academic Editor: Laura Rinaldi

Copyright © 2016 Martina Sombetzki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. A. Andrade, “Schistosomiasis and liver fibrosis,” Parasite Immunology, vol. 31, no. 11, pp. 656–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Gryseels, K. Polman, J. Clerinx, and L. Kestens, “Human schistosomiasis,” The Lancet, vol. 368, no. 9541, pp. 1106–1118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Loebermann, M. Sombetzki, C. Langner et al., “Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis,” Tropical Medicine & International Health, vol. 14, no. 11, pp. 1418–1425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W. St. C. Symmers, “Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia hæmatobia,” The Journal of Pathology and Bacteriology, vol. 9, no. 2, pp. 237–239, 1904. View at Publisher · View at Google Scholar
  5. R. A. Wilson, X. Li, and W. Castro-Borges, “Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?” Parasites & Vectors, vol. 9, no. 1, article 89, 2016. View at Publisher · View at Google Scholar
  6. L. R. Brunet, D. W. Dunne, and E. J. Pearce, “Cytokine interaction and immune responses during Schistosoma mansoni infection,” Parasitology Today, vol. 14, no. 10, pp. 422–427, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Vereecken, C. W. A. Naus, K. Polman et al., “Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni,” Tropical Medicine & International Health, vol. 12, no. 3, pp. 431–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Sombetzki, C. D. Fuchs, P. Fickert et al., “24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis,” Journal of Hepatology, vol. 62, no. 4, pp. 871–878, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Sauer, “The use of human hepatocytes for determining liver function and liver regeneration,” PCT/EP 2007/001047; DE/2006 102006005526.
  10. M. Sauer, C. Haubner, T. Mencke et al., “Impaired cell functions of hepatocytes incubated with plasma of septic patients,” Inflammation Research, vol. 61, no. 6, pp. 609–616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Scudiero, R. H. Shoemaker, K. D. Paull et al., “Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines,” Cancer Research, vol. 48, no. 17, pp. 4827–4833, 1988. View at Google Scholar · View at Scopus
  12. K. Kloetzel, “Splenomegaly in schistosomiasis mansoni,” The American Journal of Tropical Medicine And Hygiene, vol. 11, pp. 472–476, 1962. View at Google Scholar · View at Scopus
  13. R. Gerspacher-Lara, R. A. Pinto-Silva, J. C. Serufo, A. A. M. Rayes, S. C. Drummond, and J. R. Lambertucci, “Splenic Palpation for the Evaluation of Morbidity due to Schistosomiasis Mansoni,” Memorias do Instituto Oswaldo Cruz, vol. 93, pp. 245–248, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Lambertucci, “Revisiting the concept of hepatosplenic schistosomiasis and its challenges using traditional and new tools,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 47, no. 2, pp. 130–136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. W. Cheever, “Quantitative comparison of the intensity of Schistosoma mansoni infections in man and experimental animals,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 63, no. 6, pp. 781–795, 1969. View at Publisher · View at Google Scholar · View at Scopus
  16. K. S. Warren, “The pathogenesis of ‘clay-pipe stem cirrhosis’ in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes,” The American Journal of Pathology, vol. 49, no. 3, pp. 477–489, 1966. View at Google Scholar · View at Scopus
  17. P. Fickert, M. Wagner, H.-U. Marschall et al., “24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice,” Gastroenterology, vol. 130, no. 2, pp. 465–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Abdul-Ghani and A. A. Hassan, “Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies,” Parasitology Research, vol. 107, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Schwartz, K. Oeser, C. P. Da Costa, L. E. Layland, and D. Voehringer, “T cell-derived IL-4/IL-13 protects mice against fatal Schistosoma mansoni infection independently of basophils,” Journal of Immunology, vol. 193, no. 7, pp. 3590–3599, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Mentink-Kane, A. W. Cheever, M. S. Wilson et al., “Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2,” Gastroenterology, vol. 141, no. 6, pp. 2200–2209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Herbert, C. Hölscher, M. Mohrs et al., “Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology,” Immunity, vol. 20, no. 5, pp. 623–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Regueira, P. M. Lepper, S. Brandt et al., “Hypoxia inducible factor-1α induction by tumour necrosis factor-α, but not by toll-like receptor agonists, modulates cellular respiration in cultured human hepatocytes,” Liver International, vol. 29, no. 10, pp. 1582–1592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. El-Saadany, H. M. Rawel, J. Raila, M. S. El-Dashloty, and F. J. Schweigert, “Antioxidants modulate the IL-6 induced inhibition of negative acute-phase protein secretion in HepG2 cells,” Cell Biochemistry and Function, vol. 26, no. 1, pp. 95–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Nakai, H. Tanaka, K. Hanada et al., “Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients,” Drug Metabolism & Disposition, vol. 36, no. 9, pp. 1786–1793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Li, A. Jahan, and J. Y. L. Chiang, “Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-Jun pathway in human liver cells,” Hepatology, vol. 43, no. 6, pp. 1202–1210, 2006. View at Publisher · View at Google Scholar · View at Scopus